In the fourth quarter of 2019, we recognized other income, net of expenses, of $54 million, increasing from a negative $2 million in the prior quarter and from an income of $16 million in the year-ago quarter, reflecting higher R&D grants in Italy associated with the IPCEI program. [["", "", "Three Months Ended", ""], ["", "December 31, 2019", "September 29,2019", "December 31, 2018"], ["", "", "(Unaudited, in millions)", ""], ["Research and development funding", "$68", "$14", "$19"], ["Phase-out and start-up costs", "(16)", "(15)", "(1)"], ["Exchange gain (loss), net", "1", "(1)", "\u2014"], ["Patent costs", "(1)", "(1)", "(1)"], ["Gain on sale of non-current assets", "1", "\u2014", "1"], ["Other, net", "1", "1", "(2)"], ["Other income and expenses, net", "$54", "$(2)", "$16"], ["As percentage of net revenues", "2.0%", "(0.1)%", "0.6%"]]